Development and validation of a machine learning model to predict the daily risk of febrile neutropenia in patients with AML undergoing chemotherapy
Anna Mervaala-Muroke, Laura Toivanen, Pia Ettala, Riikka Räty, Mikko Keränen, Oscar Brück
Springer Nature ·
2026-11-13
· DOI 10.1038/s43856-026-02001-x
Аннотация
Communications Medicine, Published online: 13 November 2026; doi:10.1038/s43856-026-02001-x Development and validation of a machine learning model to predict the daily risk of febrile neutropenia in patients with AML undergoing chemotherapy
Anna Mervaala-Muroke, Laura Toivanen, Pia Ettala, Riikka Räty, Mikko Keränen, Oscar Brück. Development and validation of a machine learning model to predict the daily risk of febrile neutropenia in patients with AML undergoing chemotherapy. // Communications Medicine. – 2026. – DOI: 10.1038/s43856-026-02001-x. – URL: https://www.nature.com/articles/s43856-026-02001-x
Anna Mervaala-Muroke, Laura Toivanen, Pia Ettala, Riikka Räty, Mikko Keränen, & Oscar Brück (2026). Development and validation of a machine learning model to predict the daily risk of febrile neutropenia in patients with AML undergoing chemotherapy. Communications Medicine. https://doi.org/10.1038/s43856-026-02001-x
Anna Mervaala-Muroke, et al. “Development and validation of a machine learning model to predict the daily risk of febrile neutropenia in patients with AML undergoing chemotherapy.” Communications Medicine, 2026. doi:10.1038/s43856-026-02001-x.
@article{MervaalaMuroke2026,
title = {Development and validation of a machine learning model to predict the daily risk of febrile neutropenia in patients with AML undergoing chemotherapy},
author = {Mervaala-Muroke, Anna and Toivanen, Laura and Ettala, Pia and Räty, Riikka and Keränen, Mikko and Brück, Oscar},
journal = {Communications Medicine},
year = {2026},
doi = {10.1038/s43856-026-02001-x},
url = {https://www.nature.com/articles/s43856-026-02001-x}
}